tiprankstipranks
Tango Therapeutics (TNGX)
NASDAQ:TNGX
US Market
TNGX
Tango Therapeutics
RESEARCH TOOLSreports
Want to see TNGX full AI Analyst Report?

Tango Therapeutics (TNGX) Income Statement

463 Followers

Tango Therapeutics Income Statement

Last quarter (Q4 2025), Tango Therapeutics's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Tango Therapeutics's net income was $-38.75M. See Tango Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 62.38M$ 42.07M$ 36.53M$ 24.86M$ 37.04M
Gross Profit
$ 60.10M$ 42.07M$ 36.53M$ 24.86M$ 37.04M
Operating Expenses
$ 171.39M$ 187.66M$ 150.70M$ 135.93M$ 95.23M
Depreciation and Amortization
$ 2.28M$ 2.50M$ 2.42M$ 1.61M$ 897.00K
EBITDA
$ -109.01M$ -143.10M$ -111.76M$ -109.46M$ -57.29M
Operating Income
$ -111.29M$ -145.59M$ -114.17M$ -111.07M$ -58.19M
Other Income/Expenses
$ 9.70M$ 15.50M$ 12.56M$ 2.95M$ 247.00K
Pretax Income
$ -101.59M$ -130.09M$ -101.61M$ -108.12M$ -57.94M
Net Income
$ -101.59M$ -130.30M$ -101.74M$ -108.18M$ -58.23M
Per Share Metrics
Basic EPS
$ -0.87$ -1.19$ -1.08$ -1.23$ -0.94
Diluted EPS
$ -0.87$ -1.19$ -1.08$ -1.23$ -0.94
Weighted Average Shares Outstanding
 116.17M 109.23M 94.57M 87.82M 62.11M
Weighted Average Shares Outstanding (Diluted)
 116.17M 109.23M 94.57M 87.82M 62.11M
Currency in USD

Tango Therapeutics Earnings and Revenue History